Sign in
4/A

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000950170-25-049297

CEO acquired 30,000 shares (option exercise)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Evans John M. CEO 2025-01-30 Option exercise 10b5-1 +30,000 $0.67 $20,100 968,659 D
Derivatives
Evans John M. CEO 2025-01-30 Option exercise · Stock Option (Right to Buy) 10b5-1 −30,000 69,336 D
Loading xslF345X05/ownership.xml…